<DOC>
	<DOCNO>NCT00873340</DOCNO>
	<brief_summary>To gather Observation data physical disability progression , safety adherence use Betaferon daily practice . Patients type Multiple Sclerosis ( MS ) ( MRRS ) ( PSMS ) , treatment Betaferon.Open Multicentric Observational study.24 months.Evaluation physical disability patient treat Betaferon , use Kurtzke 's expanded disability scale ( EDSS ) biannual period</brief_summary>
	<brief_title>Physical Disability Patients Treated With Betaferon</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon beta-1b</mesh_term>
	<criteria>Patients first demyelinate event suggestive MS , well patient remittent recurrent MS ( RRMS ) , secondary progressive MS ( SPMS ) primary progressive MS ( PPMS ) able join study . Pregnancy Patients history hypersensitivity natural recombinant interferonbeta , human albumin excipients Patients history severe depressive disorder and/or suicidal ideation Patient decompensated liver disease Patient epilepsy adequately control treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>MS</keyword>
	<keyword>Multiple Sclerosis</keyword>
	<keyword>Betaferon</keyword>
	<keyword>Colombia</keyword>
</DOC>